Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
Authors
Keywords
-
Journal
Hepatology International
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-21
DOI
10.1007/s12072-023-10599-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy
- (2023) Chao An et al. CANCER
- Combination immunotherapy for hepatocellular carcinoma
- (2023) Lorenza Rimassa et al. JOURNAL OF HEPATOLOGY
- Lung cancer immunotherapy: progress, pitfalls, and promises
- (2023) Aritraa Lahiri et al. Molecular Cancer
- Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
- (2022) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial
- (2022) Kanglian Zheng et al. RADIOLOGY
- Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
- (2022) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment
- (2022) Kazuomi Ueshima et al. Liver Cancer
- Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy
- (2022) Xiaoping Yi et al. Frontiers in Oncology
- Hepatic artery infusion chemotherapy (HAIC) combined with apatinib and camrelizumab for hepatocellular carcinoma (HCC) in BCLC stage c: A prospective, single-arm, phase II trial (TRIPLET study).
- (2022) Yang-Kui Gu et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study
- (2022) Shiguang Chen et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
- (2022) Yujing Xin et al. Frontiers in Immunology
- PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
- (2022) Peng Liu et al. OncoImmunology
- LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
- (2022) S. Qin et al. ANNALS OF ONCOLOGY
- Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial
- (2022) ZhiCheng Lai et al. EUROPEAN JOURNAL OF CANCER
- Hepatic arterial infusion chemotherapy and sequential ablation treatment in large hepatocellular carcinoma
- (2022) Huimin You et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study
- (2022) Jiongliang Wang et al. Journal of Hepatocellular Carcinoma
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- (2022) Clinical and Molecular Hepatology
- Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study
- (2022) Shao-Hua Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Evolving therapeutic landscape of advanced hepatocellular carcinoma
- (2022) Chen Yang et al. Nature Reviews Gastroenterology & Hepatology
- Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization
- (2021) Shu-Jung Hsu et al. ACADEMIC RADIOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- (2021) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
- (2021) Jie Mei et al. Frontiers in Oncology
- Pattern of macrovascular invasion in hepatocellular carcinoma
- (2021) Maria Guarino et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
- (2021) Masatoshi Kudo et al. Liver Cancer
- Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma
- (2021) Run-Bin Liang et al. Frontiers in Oncology
- Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
- (2021) Jie Mei et al. Journal of Hepatocellular Carcinoma
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma
- (2021) Yangxun Pan et al. ANNALS OF SURGICAL ONCOLOGY
- Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 staining: a multicenter retrospective study
- (2021) Song Chen et al. BMC CANCER
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
- (2021) Qi-Jiong Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1)
- (2021) Ning Lyu et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
- (2021) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice
- (2021) Shaohua Li et al. Hepatobiliary Surgery and Nutrition
- Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
- (2021) Jingjun Huang et al. Journal of Hepatocellular Carcinoma
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
- (2020) L.-T. Chen et al. ANNALS OF ONCOLOGY
- Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial
- (2020) Shaohua Li et al. ANNALS OF SURGICAL ONCOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study
- (2020) Shiguang Chen et al. EUROPEAN JOURNAL OF CANCER
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
- (2020) Kazuomi Ueshima et al. Liver Cancer
- Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy
- (2020) Hanzhang Zhu et al. CELLULAR ONCOLOGY
- The predictive value of future liver remnant function after liver resection for HCC in noncirrhotic and cirrhotic patients
- (2019) Elisabeth Blüthner et al. HPB
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread
- (2019) Ning Lyu et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
- (2019) MinKe He et al. JAMA Oncology
- Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Maigeng Zhou et al. LANCET
- Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
- (2019) Masaaki Kondo et al. BMC CANCER
- The chances of hepatic resection curing hepatocellular carcinoma
- (2019) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
- (2018) Jong Hwan Choi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis
- (2018) Min-Ke He et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
- (2018) Ning Lyu et al. JOURNAL OF HEPATOLOGY
- Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
- (2018) Sheng-Nan Lu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Comparison of Stable and Unstable Ethiodized Oil Emulsions for Transarterial Chemoembolization of Hepatocellular Carcinoma: Results of a Single-Center Double-Blind Prospective Randomized Controlled Trial
- (2018) Min-Ke He et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma
- (2017) Ning Lyu et al. GUT
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Chemotherapy for hepatocellular carcinoma: current status and future perspectives
- (2017) Masafumi Ikeda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis
- (2017) Bas Groot Koerkamp et al. JOURNAL OF CLINICAL ONCOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis
- (2017) Alessandro Granito et al. LANCET ONCOLOGY
- A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
- (2017) Peter M Bruno et al. NATURE MEDICINE
- Validation and ranking of seven staging systems of hepatocellular carcinoma
- (2017) Zhan-Hong Chen et al. Oncology Letters
- Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
- (2016) M. Ikeda et al. ANNALS OF ONCOLOGY
- Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma
- (2016) Seiji Tsunematsu et al. HEPATOLOGY RESEARCH
- The lack of Raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells
- (2016) S Q Ma et al. ONCOGENE
- Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment
- (2016) Masatoshi Kudo et al. Liver Cancer
- Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion
- (2015) Jing Jian Sun et al. ANNALS OF SURGICAL ONCOLOGY
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus
- (2015) Zong-ming Zhang et al. International Journal of Surgery
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment
- (2015) Chen-Chun Lin et al. Liver Cancer
- Current Status of Hepatic Arterial Infusion Chemotherapy
- (2015) Shuntaro Obi et al. Liver Cancer
- Comparison of Complete Pathologic Response and Hepatic Injuries Between Hepatic Arterial Infusion and Systemic Administration of Oxaliplatin in Patients with Colorectal Liver Metastases
- (2014) Marc Antoine Allard et al. ANNALS OF SURGICAL ONCOLOGY
- Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
- (2014) Takahide Nakazawa et al. BMC GASTROENTEROLOGY
- Prognosis of untreated hepatocellular carcinoma
- (2014) Edoardo G. Giannini et al. HEPATOLOGY
- Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
- (2014) Takeshi Terashima et al. HEPATOLOGY RESEARCH
- A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
- (2014) Do Seon Song et al. JOURNAL OF GASTROENTEROLOGY
- Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
- (2014) Lei Yin et al. JOURNAL OF HEPATOLOGY
- Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Retrospective Controlled Study
- (2014) Kangshun Zhu et al. RADIOLOGY
- JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
- (2014) Masatoshi Kudo et al. Liver Cancer
- Outcome Analysis of a Decade-Long Experience of Isolated Hepatic Perfusion for Unresectable Liver Metastases at a Single Institution
- (2013) Deepa Magge et al. ANNALS OF SURGERY
- Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
- (2013) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors
- (2013) Shu-Hong Li et al. MEDICAL ONCOLOGY
- Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-Medicare
- (2013) Fadia T. Shaya et al. PHARMACOECONOMICS
- Biomarkers: Evaluation of Screening for and Early Diagnosis of Hepatocellular Carcinoma in Japan and China
- (2013) Peipei Song et al. Liver Cancer
- Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy
- (2012) Takashi Niizeki et al. JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Treatment of Advanced Hepatocellular Carcinoma with Emphasis on Hepatic Arterial Infusion Chemotherapy and Molecular Targeted Therapy
- (2012) Masatoshi Kudo Liver Cancer
- Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
- (2011) W. Joost Lesterhuis et al. JOURNAL OF CLINICAL INVESTIGATION
- Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma
- (2011) Myoung Ha Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study
- (2010) Maïté Lewin et al. EUROPEAN RADIOLOGY
- Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy
- (2009) Dirk Theile et al. BIOCHEMICAL PHARMACOLOGY
- Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
- (2009) W M Liu et al. BRITISH JOURNAL OF CANCER
- Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
- (2008) Howard S. Hochster et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now